483 related articles for article (PubMed ID: 18707547)
21. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
22. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
Santos RF; Oliveira L; Brown MH; Carmo AM
Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the tyrosine phosphorylation and calcium fluxing of human CD6 isoforms with different cytoplasmatic domains.
Kobarg J; Whitney GS; Palmer D; Aruffo A; Bowen MA
Eur J Immunol; 1997 Nov; 27(11):2971-80. PubMed ID: 9394826
[TBL] [Abstract][Full Text] [Related]
24. Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis.
Martínez-Florensa M; Català C; Velasco-de Andrés M; Cañadas O; Fraile-Ágreda V; Casadó-Llombart S; Armiger-Borràs N; Consuegra-Fernández M; Casals C; Lozano F
Front Immunol; 2018; 9():627. PubMed ID: 29706953
[TBL] [Abstract][Full Text] [Related]
25. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
26. Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.
Bajorath J; Bowen MA; Aruffo A
Protein Sci; 1995 Aug; 4(8):1644-7. PubMed ID: 8520490
[TBL] [Abstract][Full Text] [Related]
27. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.
Piazza T; Cha E; Bongarzone I; Canevari S; Bolognesi A; Polito L; Bargellesi A; Sassi F; Ferrini S; Fabbi M
J Cell Sci; 2005 Apr; 118(Pt 7):1515-25. PubMed ID: 15769845
[TBL] [Abstract][Full Text] [Related]
28. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
29. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
[TBL] [Abstract][Full Text] [Related]
30. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and regulation of CD6 on T-cell subsets revealed by monoclonal antibody (MAb) CH11.
Bank I; Dardik R; Levy V; Goldstein I; Shoham J
Hybridoma; 2001 Apr; 20(2):75-84. PubMed ID: 11394533
[TBL] [Abstract][Full Text] [Related]
32. Expression and characterization of a novel CD6 ligand in cells derived from joint and epithelial tissues.
Saifullah MK; Fox DA; Sarkar S; Abidi SM; Endres J; Piktel J; Haqqi TM; Singer NG
J Immunol; 2004 Nov; 173(10):6125-33. PubMed ID: 15528349
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
Chrétien I; Helm BA; Marsh PJ; Padlan EA; Wijdenes J; Banchereau J
J Immunol; 1988 Nov; 141(9):3128-34. PubMed ID: 2459242
[TBL] [Abstract][Full Text] [Related]
34. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
[TBL] [Abstract][Full Text] [Related]
35. Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69.
Sánchez-Mateos P; Sánchez-Madrid F
Eur J Immunol; 1991 Oct; 21(10):2317-25. PubMed ID: 1717281
[TBL] [Abstract][Full Text] [Related]
36. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
37. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
[TBL] [Abstract][Full Text] [Related]
38. Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation.
Swack JA; Gangemi RM; Rudd CE; Morimoto C; Schlossman SF; Romain PL
Mol Immunol; 1989 Nov; 26(11):1037-49. PubMed ID: 2481822
[TBL] [Abstract][Full Text] [Related]
39. Partial cDNA sequences of bovine CD72 and CD166/ALCAM, ligands for SRCR-family accessory molecules CD5 and CD6.
Rogers AN; Welte S; Black SJ; Baldwin CL
Vet Immunol Immunopathol; 2002 Mar; 85(3-4):233-9. PubMed ID: 11943324
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.
Patel DD; Wee SF; Whichard LP; Bowen MA; Pesando JM; Aruffo A; Haynes BF
J Exp Med; 1995 Apr; 181(4):1563-8. PubMed ID: 7535342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]